Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Learn which cash back cards are best this year and make informed decisions for your spending. Start saving today!
27,489 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
U.S. stocks climbed as data suggested resilience in growth and jobs. Analysts weigh whether the economy really perfor...
A look back at how a $1,000 investment split between Visa and AMEX in 2016 would fare today, highlighting the differe...
Broadcom posted a robust Q2 with AI-driven revenue rising sharply, but the stock pulled back. A bold market thesis, h...
Better Home & Finance Holding Co. posted a strong Q4 2025 lift in loan originations driven by Tinman AI, but the comp...
Investors are watching a busy 2026 IPO calendar as mega listings loom. Market watchers say AI momentum will shape dem...
Arizona robotics builder FrameTec is expanding its automated framing operation to slash build-cycle times and reduce ...
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
A notable fund pulled out of a multi-million dollar DNOW position last quarter, triggering questions about strategy a...
A sudden fire in New Jersey claimed Paul Avery and his wife, a reminder that solid financial planning safeguards love...
When a viral moment brings bhad bhabie sophie rain into the same frame, it sparks a bigger conversation about money, ...
As Scottsdale market conditions tighten, retiring at 60 demands careful budgeting. This report breaks down real costs...